Cambridge, UK – Cresset, an innovative provider of integrated in silico solutions for drug discovery, announces an extension of the global collaboration with Enamine, the world’s leading chemical and biological contract research organization and producer of novel building blocks for drug design, in the area of targeted protein degradation (TPD). TPD is an exciting research […]
Major software release enables breeding and crop protection organizations to automate and scale up R&D workflows via a single digital platform Basel, Switzerland — Genedata, the leading provider of enterprise software solutions for biotechnology R&D, today announced a new release of Genedata Selector®️, an end-to-end platform that enables agricultural biotechnology organizations to develop innovative seeds […]
Global biopharma leader drives digital innovation, data sciences, and next-generation automation approaches with Genedata’s cloud-based Biopharma Platform Basel, Switzerland — Genedata, a leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that GSK, a leading biopharma company, has extended the use of Genedata Biologics®️; to new application areas in data sciences, analytics, and […]
The hospital will use the SOPHiA DDM™ Platform to enhance its testing and research of blood cancers BOSTON and ROLLE, Switzerland — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a leader in data-driven medicine, today announced that L’hôpital Universitaire Avicenne is implementing the SOPHiA DDM™ Platform. The hospital, located in Bobigny, France, will use the […]
LAUSANNE, Switzerland — Saphetor SA, the creators of the global human genetics community VarSome, today announced European CE mark approval of the VarSome Clinical platform for the automated variant discovery, annotation, and interpretation of Next Generation Sequencing (NGS) data in compliance with the European Union’s In-Vitro Diagnostic Medical Devices Regulation (IVDR) (EU Regulation 2017/746 on IVD […]
OncoHelix is the first laboratory in Canada to adopt MSK-ACCESS® powered with SOPHiA DDM™ BOSTON and ROLLE, Switzerland — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a leader in data-driven medicine, announced today that OncoHelix, an internationally recognized research and diagnostics laboratory for precision diagnostics, will implement MSK-ACCESS® powered with SOPHiA DDM™. The organization, which currently uses the SOPHiA […]
New funding will expand CytoReason’s disease models and proprietary data, enabling R&D leaders at partner companies to make strategic decisions with greater speed and precision. CytoReason will use this investment to expand the application of its models into additional indications, grow its proprietary molecular and clinical data, and establish an office in Cambridge, Massachusetts later […]
The three-year extension expands the range of therapeutic areas and genomic data insights and also explores the use of genomic risk to better define patient subgroups OXFORD, England — Genomics plc (Genomics), a healthcare company transforming health through the power of genomics today announced a three-year extension of the company’s collaboration with Vertex Pharmaceuticals Incorporated (Vertex) (Nasdaq: VRTX) to […]
Cutting-edge biotech builds on best-in-class software to automate R&D workflows for designing novel drug candidates using machine learning approaches Basel, Switzerland — Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that BioCopy, a research-based biotechnology company and innovator in combining artificial intelligence with end-to-end automated protein engineering to generate safe […]
BugSeq, an innovative biotech company that provides a user-friendly and rapid bioinformatics platform for clinical and public health laboratories, announces it has entered a public-private partnership with the Biomedical Advanced Research and Development Authority‘s (BARDA) Division of Research, Innovation, and Ventures (DRIVe) to develop an artificial intelligence (AI)-powered reporting tool for clinical metagenomics data. BARDA is […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
